Corteva, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

Corteva, Inc. (CTVA) Hit a 52 Week High, Can the Run Continue?

AI-generated analysis

πŸ“ˆ Corteva, Inc. stock rose 11.8% over the past month and reached a new 52-week high of $85.63.

πŸ† The company has beaten earnings estimates for four consecutive quarters, including an EPS of $0.22 in February 2026.

πŸ“Š Analysts forecast current year earnings of $3.63 per share on revenues of $18.09 billion.

πŸ’° Next year's expected earnings are projected at $3.99 per share with revenues of $18.76 billion.

🎯 Corteva holds a Zacks Rank of #2 (Buy) driven by positive earnings estimate revisions.

πŸ“ Valuation metrics show the stock trades at 23.5X forward EPS and 16.6X trailing cash flow.

🧠 Style Scores indicate a C for Value, B for Growth, and B for Momentum, resulting in a VGM Score of B.

🌾 The Agriculture - Operations industry is currently positioned in the top 29% of all tracked industries.

➑️ Peer company Archer Daniels Midland Company (ADM) is also rated with a Zacks Rank #1 (Strong Buy).

πŸ’Ή ADM stock has gained 4% recently and trades at a forward P/E of 16.71X.

πŸ“‰ Corteva's Value Score of C suggests the stock trades at a premium compared to industry peers at 14.4X.

⚠️ Investors are encouraged to evaluate whether the current valuation has outpaced the company's fundamentals.

πŸ›’ A combined Zacks Rank and Style Scores approach is recommended for selecting stocks with growth potential.

πŸ“„ This analysis was originally published on Zacks Investment Research and highlights free stock reports available.

Bullish Signals
  • Shares of Corteva, Inc. (CTVA) have been strong performers lately, up 11.8% over the past month.
  • The stock hit a new 52-week high of $85.63 in the previous session and has gained 27.3% since the start of the year.
  • Corteva, Inc. has beaten the Zacks Consensus Estimate in each of the last four quarters, demonstrating consistent earnings surprises.
  • For the current fiscal year, the company is expected to post EPS of $3.63 per share on revenues of $18.09 billion.
  • For the next fiscal year, Corteva, Inc. is expected to earn $3.99 per share on $18.76 in revenues, representing a 9.81% year-over-year change.
  • The stock carries a Zacks Rank of #2 (Buy) thanks to a solid earnings estimate revision trend.
  • Corteva, Inc. has a VGM Score of B with Growth and Momentum Scores of B, indicating strong growth and momentum characteristics.
  • The Agriculture - Operations industry is in the top 29% of all industries tracked, providing favorable tailwinds for CTVA.
  • Analyst peer Archer Daniels Midland Company (ADM) also shows strength with a Zacks Rank of #1 (Strong Buy) and recent earnings that beat consensus estimates by 4.82%.
Risk Factors
  • Corteva, Inc. trades at a premium valuation of 23.5X forward EPS estimates compared to the peer industry average of 14.4X, suggesting the stock may be overvalued relative to competitors.
  • On a trailing cash flow basis, Corteva is valued at 16.6X versus its peer group's average of 8X, indicating a significant pricing disadvantage for value-oriented investors.
  • The stock carries a PEG ratio of 2.91, which is high and suggests that current growth expectations are not fully priced in or may be optimistic given the valuation level.
  • While positive earnings surprises have occurred recently, relying on four consecutive beats without underlying structural change creates sustainability risks as estimates likely tighten over time.
  • The company's Value Score of C indicates that it falls short on value metrics compared to higher-rated peers like Archer Daniels Midland Company, which holds a B-grade Value Score.
  • Industry tailwinds may not persist indefinitely if the Agriculture - Operations industry growth rate slows, as current projections show modest revenue growth of only 3.98% for the current fiscal year.
  • Corteva's high valuation relative to peers limits potential upside if market sentiment shifts or if competitor earnings outperform without a corresponding stock price move.
Full Analysis
Shares of Corteva, Inc. (CTVA) have recently reached a new 52-week high of $85.63, marking an impressive outperformance against broader market indices with the stock up 11.8% over the past month and 27.3% year-to-date compared to sector averages. The company has demonstrated strong recent earnings momentum, beating the Zacks Consensus Estimate in each of the last four quarters, including reporting EPS of $0.22 versus a consensus estimate of $0.21 in its most recent earnings report on February 3, 2026. For the current fiscal year, analysts expect Corteva to post earnings of $3.63 per share on revenues of $18.09 billion, while next fiscal year projections stand at $3.99 per share on $18.76 billion in revenues, representing anticipated growth rates of 8.68% and 9.81%, respectively. Despite the positive momentum, valuation metrics present a mixed picture for investors assessing the company's future trajectory. Corteva currently trades at 23.5X current fiscal year EPS estimates and 16.6X trailing cash flow basis, figures that significantly exceed the peer industry averages of 14.4X and 8X, respectively. The stock holds a PEG ratio of 2.91 and carries a Zacks Style Score combination (VGM) of B based on individual Value (C), Growth (B), and Momentum (B) scores. However, the company maintains a Zacks Rank of #2 (Buy), which is bolstered by a solid earnings estimate revision trend and aligns with investment criteria for stocks carrying Ranks of 1 or 2 alongside Style Scores of A or B. In addition to Corteva's individual fundamentals, the broader Agriculture - Operations industry remains in the top 29% across the Zacks universe, suggesting positive tailwinds for holdings like Archer Daniels Midland Company (ADM). ADM currently boasts a Zacks Rank of #1 (Strong Buy) with Value and Momentum scores of B and Growth score of D, supported by recent earnings that beat consensus estimates by 4.82%. The company is projected to earn $4.32 per share on $84.27 billion in revenue for the current fiscal year, trading at a forward P/E of 16.71X and P/CF of 12.2X, having gained 4% over the past month. While Corteva appears to remain a viable investment option with potential for further growth, investors should consider its relative valuation premiums compared to industry peers alongside the favorable positioning of the broader agricultural sector.